Evidence map›Paper›PMID 21368890›Full record

ArticleCell death & disease2011

S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism.

A Kumar, B Oskouian, H Fyrst, M Zhang, F Paris, J D Saba

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06864221 (Correlation Between Plasma Sphingolipid Metabolites and the Efficacy of Radiotherapy in Hepatocellular Carcinoma), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06864221 recruitingnot on this mapstarted 2024, after this paper: background citation

Correlation Between Plasma Sphingolipid Metabolites and the Efficacy of Radiotherapy in Hepatocellular Carcinoma

TypeobservationalSponsorNanfang Hospital, Southern Medical UniversityRan2024 to 2026Enrolled260ConditionsHepatocellular Carcinoma, Radiotherapy, Treatment Outcome, Biomarkers
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The role of lipid metabolism in cancer radioresistance.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  5. Article
  6. Article
  7. Multi-Omics Integration Highlights the Role of Ubiquitination in CClInternational journal of molecular sciences · 2020
    Article
  8. SGPL1Cancer gene therapy · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease.International journal of molecular sciences · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

A KumarCenter for Cancer Research, Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609-1673, USA.
B Oskouian
H Fyrst
M Zhang
F Paris
J D Saba
Center for Cancer Research · USOakland University · USInserm · FR

Funding

SPHINGOSINE--REGULATION AND POTENTIAL ROLE IN CANCERR01CA077528 · NCI · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI SABA, JULIE D · 1998 to 2009
$2.8M
Endogenous sphingosine-1-phosphate as a radioprotector of intestinal tissuesRC1AI078516 · NIAID · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI SABA, JULIE D · 2007 to 2010
$825k
NCI NIH HHS CA77528NCI NIH HHS R01 CA077528NIAID NIH HHS AI078516NIAID NIH HHS RC1 AI078516
6 · The paper itself

Abstract

The injurious consequences of ionizing radiation (IR) to normal human cells and the acquired radioresistance of cancer cells represent limitations to cancer radiotherapy. IR induces DNA damage response pathways that orchestrate cell cycle arrest, DNA repair or apoptosis such that irradiated cells are either repaired or eliminated. Concomitantly and independent of DNA damage, IR activates acid sphingomyelinase (ASMase), which generates ceramide, thereby promoting radiation-induced apoptosis. However, ceramide can also be metabolized to sphingosine-1-phosphate (S1P), which acts paradoxically as a radioprotectant. Thus, sphingolipid metabolism represents a radiosensitivity pivot point, a notion supported by genetic evidence in IR-resistant cancer cells. S1P lyase (SPL) catalyzes the irreversible degradation of S1P in the final step of sphingolipid metabolism. We show that SPL modulates the kinetics of DNA repair, speed of recovery from G2 cell cycle arrest and the extent of apoptosis after IR. SPL acts through a novel feedback mechanism that amplifies stress-induced ceramide accumulation, and downregulation/inhibition of either SPL or ASMase prevents premature cell cycle progression and mitotic death. Further, oral administration of an SPL inhibitor to mice prolonged their survival after exposure to a lethal dose of total body IR. Our findings reveal SPL to be a regulator of ASMase, the G2 checkpoint and DNA repair and a novel target for radioprotection.

Indexed as

DNA DamageAldehyde-LyasesAnimalsCell CycleFemaleHEK293 CellsHumansLysophospholipidsMiceMice, Inbred C57BLRadiation, IonizingSphingolipidsSphingomyelin PhosphodiesteraseSphingosineAldehyde-LyasesLysophospholipidsSphingolipidsSphingomyelin PhosphodiesteraseSphingosinesphingosine 1-phosphatesphingosine 1-phosphate lyase (aldolase)

Identifiers

PMID21368890
PMCPMC3101703
OpenAlexW2003769596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.